Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00089154
What this trial is testing

Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Noncontiguous Stage II Small Lymphocytic LymphomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+2 more
National Cancer Institute (NCI) 32
Not applicableLooking for participantsNCT06141798
What this trial is testing

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

Who this might be right for
Age ProblemDialysis; ComplicationsFrailty+1 more
Soonchunhyang University Hospital 428
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Not applicableUnknownNCT06426212
What this trial is testing

Use of Teicoplanin on a Three-weekly Administration in the Infectious Diseases Unit

Who this might be right for
Comparison of Teicoplanin Used Three Times a Week in DSIs vs NDISs
Azienda Ospedaliera di Lecco 40
Not applicableNot Yet RecruitingNCT07735975
What this trial is testing

Effects and Mechanisms of Temporal Interference Stimulation (TIS) on Neuropathic Pain

Who this might be right for
Neuropathic PaintTIS
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Post-approval studies (Phase 4)Study completedNCT01109160
What this trial is testing

Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation

Who this might be right for
Lymphocytic Bronchi(Oli)Tis Post-lung Transplantation
KU Leuven 15
Large-scale testing (Phase 3)Study completedNCT03740048
What this trial is testing

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease

Who this might be right for
End Stage Renal Failure on Dialysis
Wake Forest University Health Sciences 51
Not applicableEnded earlyNCT03415776
What this trial is testing

Twice Against Thrice-weekly Hemodialysis

Who this might be right for
Hemodialysis Complication
Saint-Joseph University 208
Large-scale testing (Phase 3)Study completedNCT00530348
What this trial is testing

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 581
Not applicableWithdrawnNCT00585234
What this trial is testing

Tools for the Objective Clinical Assessment of Pediatric Spinal Deformity

Who this might be right for
Thoracic Insufficiency SyndromeTIS
University of Utah
Not applicableLooking for participantsNCT07745673
What this trial is testing

Comparative Study of TIS Efficacy Across Different Targets

Who this might be right for
PARKINSON DIS
Zhongnan Hospital 18
Early research (Phase 1)Study completedNCT00017472
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNoncontiguous Stage II Marginal Zone Lymphoma+11 more
National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Study completedNCT00548405
What this trial is testing

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 840
Large-scale testing (Phase 3)Study completedNCT04130828
What this trial is testing

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

Who this might be right for
Iron Deficiency Anemia
Prince of Songkla University 66
Not applicableLooking for participantsNCT07771036
What this trial is testing

Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment (MCI)
Shanghai University of Sport 21
Large-scale testing (Phase 3)Study completedNCT00698334
What this trial is testing

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeTuberculosis
All India Institute of Medical Sciences 150
Post-approval studies (Phase 4)Study completedNCT00413803
What this trial is testing

Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis

Who this might be right for
End-Stage Renal DiseaseHemodialysis
Ege University 410
Not applicableStudy completedNCT03352271
What this trial is testing

Individualized Incremental Hemodialysis Study

Who this might be right for
Hemodialysis ComplicationESRDRenal Failure
Alexandria University 122
Large-scale testing (Phase 3)Study completedNCT00943995
What this trial is testing

Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis

Who this might be right for
Kidney Failure, ChronicRenal Dialysis
Nationwide Children's Hospital 3
Testing effectiveness (Phase 2)Study completedNCT01514370
What this trial is testing

Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 80
Next Page